Antiviral and Ankylosing spondylitis

Summary:

Ankylosing spondylitis is found among people with Antiviral, especially for people who are male, 40-49 old.

The study analyzes which people have Ankylosing spondylitis with Antiviral. It is created by eHealthMe based on reports of 21 people who have Antiviral from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Antiviral?

Antiviral is found to be associated with 5 drugs and 9 conditions by eHealthMe. Check the latest studies of Antiviral.

What is Ankylosing spondylitis?

Ankylosing spondylitis (type of arthritis affecting the spine) is found to be associated with 746 drugs and 1,048 conditions by eHealthMe. Check the latest studies of Ankylosing spondylitis.



On Jul, 15, 2026

21 people who have Antiviral and Ankylosing Spondylitis are studied.

Would you have Ankylosing spondylitis when you have Antiviral?

Gender of people who have Antiviral and experienced Ankylosing Spondylitis *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Antiviral and experienced Ankylosing Spondylitis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 90 %
  • 50-59: 0.0 %
  • 60+: 10 %

Common co-existing conditions for these people *:

  1. Psoriasis (immune-mediated disease that affects the skin): 19 people, 90.48%
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints): 18 people, 85.71%
  3. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 9 people, 42.86%
  4. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 9.52%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
  6. Dyslipidaemia (abnormal amount of lipids): 2 people, 9.52%
  7. Diabetes: 2 people, 9.52%
  8. Constipation: 2 people, 9.52%

Common drugs taken by these people *:

  1. Erelzi: 9 people, 42.86%
  2. Enbrel: 8 people, 38.10%
  3. Sulfasalazine: 4 people, 19.05%
  4. Celecoxib: 4 people, 19.05%
  5. Pyrazinamide: 4 people, 19.05%
  6. Nabumetone: 4 people, 19.05%
  7. Methylprednisolone: 4 people, 19.05%
  8. Methotrexate: 4 people, 19.05%
  9. Leflunomide: 4 people, 19.05%
  10. Acyclovir: 4 people, 19.05%

Common symptoms for these people *:

  1. Ascites (accumulation of fluid in the abdominal cavity): 19 people, 90.48%
  2. Granuloma (a small area of inflammation due to tissue injury): 19 people, 90.48%
  3. Upper Gastrointestinal Haemorrhage (upper gastrointestinal bleeding): 19 people, 90.48%
  4. Liver Function Test Abnormal: 19 people, 90.48%
  5. Splenomegaly (enlargement of spleen): 19 people, 90.48%
  6. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 19 people, 90.48%
  7. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 19 people, 90.48%
  8. Sepsis (a severe blood infection that can lead to organ failure and death): 19 people, 90.48%
  9. Encephalopathy (functioning of the brain is affected by some agent or condition): 19 people, 90.48%
  10. Jaundice - Yellow Skin (a yellowish pigmentation of the skin): 18 people, 85.71%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Ankylosing spondylitis?

- Check whether Ankylosing spondylitis is associated with a drug or a condition


Related publications that referenced our studies

Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Ankylosing spondylitis:

All the conditions that are associated with Ankylosing spondylitis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Ankylosing spondylitis and Antiviral, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: